Male obesity is associated with physiological changes that can negatively affect male fertility. Obese men have demonstrated a 3-fold increase in the prevalence of oligozoospermia when compared with men with normal Body Mass IndexBMI .The experiment was conducted to find the correlation between Aromatase enzyme and FSH, LH, E2 , testosterone and BMI.
INTRODUCTION
Male factor infertility is associated with a higher incidence of obesity and it is well recognized as a risk factor for female infertility. Male fertility both directly and indirectly has been proposed to be affected by obesity, which inducing variation in erectile dysfunction, hormonal profiles behaviour, scrotal temperatures and sleep (1) .
The relationship between infertility and male obesity can be attributed to more than just sexual dysfunction and other altered physical manifestations of obesity. Erectile dysfunction is significantly associated with overweight or obesity, and about 76% of men who reported with an erectile dysfunction or decrease in libido are overweight or obese (2) . Regarding the hormonal profile, there is a complicated network of hormones negative and positive feedback mechanisms which include testosterone, FSH, LH and E2 (3) .
Aromatase enzyme (called estrogen synthetize or estrogen synthase) converts androgen hormones, which are involved in the sexual development of the male, to another forms of the female sex hormone estrogen. Aromatase alter testosterone to estradiol and androstenedione to estrone (4) The location of aromatase enzyme is in theendoplasmic reticulam of the cell, where it is well-regulated by tissuespecific promotors that are in turn controlled by cytokines,hormones , and other factors. The last steps of estrogens biosynthesis from androgens catalyzed by this enzyme, specifically it convert androstenedione (the common precursor of male and female sex hormones to E1 andtestosterone to E2 (6) .
Some unanimity on the effects of obesity on sperm motility has been established, however there is no complete agreement. Researchers found that sperm motility correlated negatively with BMI, and concluded that the incidence of low progressively motile sperm count increased with increasing BMI (7).
Some studies concluded that the total motile sperm count as well as the rapid progressively sperm motility correlated negatively with the waist and hip circumference of men.
Despite this evidence, not all studies have included sperm motility within their measurement parameters, and other studies have found no effect of (BMI) or obesity on sperm motility (3).
A decrease in the testosterone -estrogen ratio is consistently displayed in obese infertile men. These obese had 6% higher levels of estradiol and 25-32% lower levels of testosterone than normal weight men (8) . The severity of obesity determines the degree to which levels of estradiol are increased and testosterone decreased (9) . On the other hand, the increased conversion of androgens into estrogens, which is characteristic of obesity, depresses the function of the pituitary gland by disturbing normal feedback in the testis. (BMI) negatively correlated with testosterone, FSH, and Inhibin B levels and positively correlated with E2 levels (3).
SUBJECTS, MATERIALS AND METHODS:
This study is carried out between 1st of July 2014 and the P-value of ≤ 0.05 was considered significant.
RESULTS:
Mean of (BMI) kg/m2 in patients and in control groups is shown in table 2. There was no significant difference in mean of (BMI) between control subjects and patients, P= 0.705. 
DISCUSSION:
Aromatase enzyme, which converts testosterone to E2, is highly expressed in peripheral fat tissue and any increase in aromatase activity is thought to result in increased E2 production, which inhibits secretion of FSH and LH from the pituitary gland (10).
The extraglandular aromatization of circulating androgen precursors is the major source of estrogen in all men.
Importantly in men the testes account at most for 15% of circulating estrogens, while the remaining 85% is due to peripheral aromatization of circulating androgen precursors in different tissues (11) , these are from adipose tissue, brain, skin, and the endothelium. Also it has been demonstrated that testicular androgen precursors contribute more to the total amount of circulating estradiol than adrenal androgens (12) .
These extragonadal sites of estrogen biosynthesis lack the ability to synthesize C19 precursors from cholesterol so, their estrogen-producing activity totally depends on the availability of these circulating C19 androgenic steroids (13) . On the other hand, the estrogen synthesized within these extragonadal compartments may be also locally active in a paracrine or intracranial fashion (14) . It is clearly that with more adipose tissue, the associated increase in adipose aromatase activity dominates any effect of the polymorphisms on intrinsic aromatase activity (15) . It is known, that aromatase is a specific marker of the undifferentiated adipose mesenchymal cell phenotype, but it is less expressed in mature adipocytes. Thus, factors that stimulate adipocyte differentiation, such as Peroxisome proliferator-activated receptor gamma (PPARγ) agonists could also lead to the down regulation of aromatase gene and a reduction in aromatase activity (16) . It is well known, if there are more adipocytes, there could be more aromatase activity even with reduced production of estrogen per fat cell.
The results of the present study demonstrated clearly that obesity may contributes to the decline in fertility rate among the studied patient group. As far as the hormones level are concerned, the FSH was significantly higher in patient group than in control group (the high difference in FSH because our patients are infertile), this result does not agree with results reported by other investigators (17) , who showed no statistically significant relationships between (BMI) and FSH hormone. Also reported by another study a lower FSH level in obese patients (1). The mean LH was not significantly different in patient group than in control group, but it seems to be slightly higher than in the controls. (MacDonald et al.) (17) demonstrated that LH does not seem to be affected by (BMI) in men. A study (18) , showed that there was no significant correlation explored between (BMI) and LH level, whereas another study (19) , found that (BMI) significantly influenced LH value. (Qin D D, et al.) (20) claimed that obesity can reduce the level of LH.
Mean estradiol was higher in patient group than in control group, although the difference was not significant, but it gives an indication that there is an association between (BMI) and an increase in this hormone. In males E2 is derived It is believed that any increase in estrogens in obese males is owing to increased conversion of testicular and adrenal androgens due to the increase in available aromatase enzyme in the fatty tissue (22) . Another study (17) , stated that the levels of estradiol generally appear unaffected by (BMI), but a few studies (23) The present study exhibited that the mean testosterone was not significantly different in patient group than in control group, a negative significant correlation was found between human cytochrome enzyme and this hormone. This result seems to be different from other studies in which obese tissue leads to the lowering of the male hormone, testosterone, which directly affects fertility. Majority of studies which investigate the effect of obesity on testosterone reported decreased levels. This reduction is may be at least in part caused by the decreasing in the sex hormone binding globulin (SHBG) levels that will influence the half-life of testosterone (28) . Whether the reduction in testosterone levels is adequate to exert a biological effect, influencing spermatogenesis, is a subject of debate.
The increasing in the number and size of adipocytes is associated with obesity. Many proposed mechanisms to explain the effect of obesity on male fertility focus on the influence of abnormal levels of adipose derived hormones and adipokines related to reproductive organs and hormones on fertility. Subcutaneous fat, intra-abdominal fat and total body fat may be associated with low levels of testosterone in males, and most obese males looking for infertility treatment present with a decreased in the testosterone ratio to estrogen (29, 30) , this decrease is explained by over activity of the human cytochrome enzyme, which is exist at high levels in the white adipose tissue and, there for, is responsible for a key step in the biosynthesis of estrogens.
Receiver operating characteristic (ROC) curve analysis was used to calculate cut off values of variables because of the presence of wide significant differences in enzyme level in both groups.
